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Abstract
Background: The Spontaneously Hypertensive Rat (SHR) shows a number of behaviours that
closely parallel those seen in children with attention-deficit hyperactivity disorder. These include
motor hyperactivity, excessive responses under a fixed-interval/extinction schedule, difficulty in
acquiring operant tasks and increased sensitivity to immediate behavioural reinforcement. As in
children with ADHD, the behavioural and cognitive deficits in the SHR are responsive to stimulants,
including d-amphetamine and d,l-methylphenidate. The non-hyperactive Wistar Kyoto (WKY) rat
strain is often used as a control in behavioural studies of the SHR, and WKY itself has been
suggested to be a useful animal model of depression. Numerous studies have shown that
dopaminergic neurotransmission is altered between the two strains. Human genetic studies have
found associations between several dopaminergic genes and both ADHD and depression.
Methods: We sequenced three candidate dopaminergic genes (Drd2, Drd4, and Dat1) in the SHR
and WKY to identify between-strain sequence differences.
Results: No between-strain sequence differences were found in either Drd2 or Drd4, but several
variations were found in the Dat1 gene that encodes the dopamine transporter.
Conclusion: It is plausible that DNA sequence changes in the Dat1 gene account for some of the
behavioural differences observed between the SHR and WKY strains. Future work will focus on
elucidating the functional effects of the observed polymorphisms.
Background
Attention-deficit hyperactivity disorder (ADHD) is a com-
mon neurobehavioural disorder defined by symptoms of
developmentally inappropriate inattention, impulsivity
and hyperactivity. It is estimated that between 3–6% of
school age children are diagnosed with ADHD, making it
the most prevalent disorder of childhood. While the pre-
cise aetiology of ADHD is yet to be ascertained, it is clear
from numerous family, twin and adoption studies that
genetic factors play in a key role in susceptibility to the
disorder. Polymorphisms in several genes have been asso-
ciated with ADHD, with a particular focus on genes impli-
cated in monoamine neurotransmission [1].
A number of animal models have been proposed for
ADHD and these have helped inform research into the
biological basis of the clinical disorder. The spontane-
ously hypertensive rat (SHR) is one of the most widely
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a number of behaviours that closely parallel those seen in
children with ADHD including motor hyperactivity,
increased impulsiveness and deficient sustained attention
[3,4]. Furthermore, like children with ADHD, the SHR is
more sensitive to immediate behavioural reinforcement
and less sensitive to delayed reinforcement than non-
hypertensive WKY control rats [3,4]. The behavioural and
cognitive deficits in the SHR are responsive to stimulants,
including d-amphetamine and d,l-methylphenidate [5].
Finally, several studies have shown that dopaminergic and
noradrenergic neurotransmission is altered in the SHR
compared to the WKY, strongly implicating these systems
in the aetiology of ADHD [2,6,7].
The WKY strain, from which the SHR was initially derived
by selective outbreeding [8], is itself proposed to be a
model of another psychiatric condition – depression. As
for ADHD, the aetiology of depression has been shown to
be strongly influenced by genetic factors [9] and dysregu-
lation of the dopaminergic system has been strongly
implicated [10]. WKY rats have been shown to exhibit
exaggerated neuroendocrine and behavioral responses to
stress that exceed normal controls and are especially
prone to develop stress-induced depressive disorder
[11,12]. A recent study by Will et al found that selectively
bred WKY rats were a particularly good animal model of
depression and hyper-responsiveness to anti-depressants
[13]. Interestingly, the dopamine neurotransmitter path-
way has been strongly implicated in the depression-like
behaviours exhibited by WKY rats. Jiao et al observed dif-
ferences in the density and distribution of dopamine
transporter sites in WKY rats that may lead to altered mod-
ulation of synaptic dopamine levels in the cell body and
mesolimbic regions [14].
In this study we have sequenced three dopaminergic can-
didate genes (Drd2, Drd4, and Dat1) in the SHR and WKY
rat strains to identify potential genetic variants that may
explain some of the behavioural differences observed
between the two strains.
Methods
Blood was obtained from animals housed at the Univer-
sity of Oslo and DNA was extracted using a standard pro-
tocol [15]. Bioinformatic analyses were performed to
identify regions in the rat genome containing homo-
logues of human ADHD candidate genes using sequence
data deposited in the Rat Genome Database http://
rgd.mcw.edu/. Where no annotated rat genome sequence
was available, BLAST searches were performed on raw
sequence data to identify the relevant regions http://
www.ncbi.nlm.nih.gov/BLAST/. Primers were designed to
span the promoter and exonic regions of three candidate
genes (Drd2, Drd4, and Dat1) using Primer Express soft-
ware (Applied Biosystems, Foster City, CA, USA). To con-
serve space oligo sequences are not given in this
manuscript, but are available from the authors on request.
The chromosomal location, amino-acid length and
human-rat homology for the three genes sequenced in
this study can be seen in Table 1.
The exonic regions were amplified on an MJ PTC-225
thermal cycler (MJ Research) with an initial 9-min dena-
turing step at 95°C, followed by 35 cycles of 93°C for 1
min, 55°C for 1 min and 72°C for 1 min, and a final
extension phase of 72°C for 10 min. Reactions were per-
formed in 22 ul volumes and included 50 ng of genomic
DNA, 1.5 mM MgCl2, 0.2 mM dNTP's, 10 mM GeneAmp
10× PCR Gold Buffer (PE Applied Biosystems, Foster City,
US) and 1 unit of AmpliTaq Gold (PE Applied Biosystems,
Foster City, US). PCR products were run out on a 2% aga-
rose gel stained with ethidium bromide and analysed
under UV light. PCR products were purified using Qiagen
Gel Extraction Columns (Qiagen, Crawley, UK). Follow-
ing purification, forward and reverse dye terminator
sequencing was carried out using ABI BigDye V3.0 and
samples run on either an ABI 377 or 3100 machine
(Applied Biosystems, Foster City, CA, USA). Sequencing
traces were analysed using Sequencher software (Gene-
Codes Corporation, Ann Arbor, MI, USA), and multiple
sequences aligned to aid mutation detection.
Results
Drd2
The rat Drd2 gene is located on chromosome 8q23 and is
95% homologous with the human DRD2 gene. The puta-
tive promoter and exonic regions of Drd2 were
sequenced. No differences were observed between the
SHR and WKY strains, and both sequences were identical
to those in the Rat Genome Database http://rgd.mcw.edu/
.
Table 1: The chromosomal location, amino-acid length and human-rat homology for the three genes sequenced in this study.
Gene Human Rat Homology
ID Location AA Location AA (%)
DRD2 11q23.2 443 8q23 444 95%
DRD4 11q15.5 387 1q41 385 75%
DAT1 5p15.33 620 1p11 619 94%Page 2 of 5
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The rat Drd4 gene is located on chromosome 1q41 and
shares 75% homology with the human DRD4 gene. The
putative promoter, exons, and introns of Drd4 were
sequenced. No differences were found between the SHR
and WKY strains, although both were found to contain
non-coding sequence differences from the Brown Norway
Rat sequence available in the Rat Genome Database (see
Table 2). These differences included two single nucleotide
polymorphisms (SNPs), one located in the putative 5'
promoter region of the gene and the other in intron 2,
along with length variation at a CA microsatellite repeat in
intron 2. In addition, neither the WKY or SHR strains were
found to have the short first intron (GGCGCG) present
between exon 1 and 2 in the sequence available in the Rat
Genome Database.
Dat1
The rat Dat1 gene is located on chromosome 1p11 and is
94% homologous with the human DAT1 gene. The puta-
tive promoter and exonic regions of Dat1 were sequenced.
The exon 3 amplicon could not initially be amplified by
PCR in the WKY strain (see Figure 1a). Subsequent PCR
amplification using more distal primers suggested the
presence of extra sequence in the SHR compared to the
WKY (see Figures 1b and 1c). Sequencing of this region
highlighted a synonymous single base change (T→C)
within the coding sequence of exon 3 (see Figure 2), and
a 160 bp section of sequence immediately upstream of
exon 3 present in SHR but not WKY. Bioinformatic analy-
sis of the public rat genome database demonstrated that
this 160 bp sequence is also present ~1000 bp upstream
(in intron 4 of Dat1).
Discussion
In this study we sequenced three dopaminergic genes to
examine differences between SHR and WKY rat strains. No
between-strain sequence differences were found in genes
encoding either the dopamine D2 receptor (Drd2) or the
dopamine D4 receptor (Drd4), although for Drd4 both
the WKY and SHR strains were found to differ from the
sequence available in the Rat Genome Database http://
rgd.mcw.edu/. In contrast, several between-strain varia-
tions were found in the dopamine transporter gene
(Dat1). Although none of the sequence changes results in
a direct coding change to the DAT protein, it is plausible
that they may alter expression-related processes such as
transcription or splicing efficiency. Alternatively, it is pos-
sible that these changes are markers of other linked muta-
tions carried on the same chromosome. These results are
interesting given that the SHR and WKY strains are consid-
ered to be valid models of ADHD and depression respec-
tively, and the postulated role of disrupted dopaminergic
neurotransmission in both disorders.
It is pertinent that abnormalities in DAT expression and
functioning have been noted in both rat strains. SHR
Table 2: Variants noted in the Drd4 gene in both WKY and SHR 




Intron 1 GGCGCG (not present in WKY/SHR)
Intron 2 CACA (2 extra CA motifs in SHR/WKY)
Intron 2 GAATGG[A/G]GACATA*
*WKY/SHR allele given second.
PCR amplification of Dat1 exon 3 using three alternative primer pairs on SHR (S) and WKY (W) DNAFigure 1
PCR amplification of Dat1 exon 3 using three alternative primer pairs on SHR (S) and WKY (W) DNA. On 
WKY DNA the reaction did not work using primer set (a) and resulted in a smaller PCR product than seen using SHR DNA 
with sets (b) and (c).Page 3 of 5
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sion in mesocortical projections [16,17]. It appears that
excess DAT expression in the SHR may not be directly
genetic in origin, but is in fact a response to excess meso-
cortical dopamine during early development resulting
from hypofunctioning DAT protein that is presumably
genetic [2,16]. The WKY strain also appears to have an
unusual DAT profile compared to non-depressive control
strains. Jiao et al report lower DAT density in the nucleus
accumbens, amygdala, ventral tegmental area, and the
reticular part of the substantia nigra of these animals, but
higher expression in the hippocampus and hypothalamus
[14].
It is interesting that these findings are partially mirrored in
studies on human psychiatric patients. Whilst individuals
with ADHD have been shown to exhibit increased DAT
density in the brain [18,19], depressive patients were
found to have overall decreased levels of DAT [20]. Fur-
thermore, genetic association studies suggests an associa-
tion between a polymorphism in the human dopamine
transporter gene (DAT1) and ADHD [21], although to
date there is no evidence linking this polymorphism to
the aetiology of depression.
Conclusion
In this study we have sequenced three dopaminergic genes
in two inbred rat strains considered to be good models of
human psychiatric illness. No between strain differences
were observed in either the Drd2 or Drd4 genes, suggesting
that neither gene is likely to mediate the behavioural dif-
ferences observed between the WKY and SHR strains,
although a number of polymorphisms common to both
strains were detected in Drd4. In contrast, WKY/SHR dif-
ferences were observed in the 3rd exon of Dat1. Whilst
these mutations do not result in direct amino-acid
changes to the DAT protein, it is possible that they medi-
ate some other process that explains the differences in
DAT expression and function observed between the two
strains. Future work should focus on further characteriz-
ing the genetic differences between these two strains, and
investigating the functional consequences of the observed
polymorphisms and how they relate to the putative
depressive and hyperactive behaviours observed in the
two strains.
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